The Effect of Continuous Strategy on Primary Outcomes of Meropenem Administration

I don't have a graph of separation because I am happy to say that my population is very well balanced in the two groups, both for severity, for duration of hospital stay and next one. They are affected usually by gram negative but some of them are affected by gram positive. So our hypothesis that continuous strategy of meropenem administration compared to the intermittent one can change the primary outcome of 28 day mortality combined to the emergence of a new extensive or pan-brag resistant bacteria. And thanks.